Weight-loss drug stocks, including Novo Nordisk, Eli Lilly, Viking Therapeutics, Amgen, and Altimmune, face political scrutiny and market volatility following President Trump’s remarks on pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback